Engene Holdings Inc. · DUS:S0N
BVF PARTNERS L P/IL reported a 5.90% stake in Engene Holdings Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 29, 2025
BVF PARTNERS L P/IL reported a 5.90% stake in Engene Holdings Inc., 3,051,439 shares, as a passive investor on Dec 31, 2024. Filed Jan 29, 2025 (Schedule 13G/A).
- Stake
- 5.90%
- Shares
- 3,051,439
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 3.10% | 1,597,986 |
| BVF I GP LLC | 3.10% | 1,597,986 |
| BIOTECHNOLOGY VALUE FUND II LP | 2.50% | 1,263,389 |
| BVF II GP LLC | 2.50% | 1,263,389 |
| Biotechnology Value Trading Fund OS LP | 0.30% | 148,043 |
| BVF Partners OS Ltd. | 0.30% | 148,043 |
| BVF GP HOLDINGS LLC | 5.50% | 2,861,375 |
| BVF PARTNERS L P/IL | 5.90% | 3,051,439 |
| BVF INC/IL | 5.90% | 3,051,439 |
| LAMPERT MARK N | 5.90% | 3,051,439 |
Source
Related
- Engene Holdings Inc.
- Bvf Partners L P
- Engene Holdings Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Jan 29, 2025
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G · Anders Hove · Jul 22, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · May 15, 2026
- Schedule 13G/A · Braden M Leonard · May 14, 2026